Study of Antiinflammatory Effects of Detralex (Daflon) in Patients With Chronic Venous Disease

Trial Profile

Study of Antiinflammatory Effects of Detralex (Daflon) in Patients With Chronic Venous Disease

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 May 2017

At a glance

  • Drugs S 5682 (Primary)
  • Indications Venous insufficiency
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 15 May 2017 Planned End Date changed from 1 Oct 2013 to 1 Dec 2017.
    • 15 May 2017 Planned primary completion date changed from 1 Oct 2013 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top